Comments
Loading...
Biodexa Pharmaceuticals (NASDAQ:BDRX) Stock, Earnings Estimates, EPS, And Revenue
Biodexa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 19
EPS
$-246.600
Quarterly Revenue
$469.8K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$83K
Analyze the earnings history of Biodexa Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Biodexa Pharmaceuticals (BDRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Biodexa Pharmaceuticals (BDRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals (BDRX) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on April 19, 2024 for FY.
What were the latest earnings per share (EPS) for Biodexa Pharmaceuticals (NASDAQ:BDRX)?
The Actual EPS was $-246.60, which missed the estimate of $0.00.
What were Biodexa Pharmaceuticals’s (NASDAQ:BDRX) revenues?
The Actual Revenue was $469.8K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.